Found: 5
Select item for more details and to access through your institution.
Anticancer Activity of an Imageable Curcuminoid 1-[2-Aminoethyl-(6-hydrazinopyridine-3-carbamidyl)-3,5-bis-(2-fluorobenzylidene)-4-piperidone (EFAH).
- Published in:
- Chemical Biology & Drug Design, 2012, v. 79, n. 2, p. 194, doi. 10.1111/j.1747-0285.2011.01271.x
- By:
- Publication type:
- Article
Nanoparticle Attachment to Erythrocyte Via the Glycophorin A Targeted ERY1 Ligand Enhances Binding without Impacting Cellular Function.
- Published in:
- Pharmaceutical Research, 2016, v. 33, n. 5, p. 1191, doi. 10.1007/s11095-016-1864-x
- By:
- Publication type:
- Article
Erythrocytes internalize nanoparticles functionalized with low molecular weight protamine.
- Published in:
- Journal of Nanoparticle Research, 2021, v. 23, n. 4, p. 1, doi. 10.1007/s11051-021-05202-8
- By:
- Publication type:
- Article
The curcuminoid CLEFMA selectively induces cell death in H441 lung adenocarcinoma cells via oxidative stress.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 558, doi. 10.1007/s10637-010-9610-4
- By:
- Publication type:
- Article
Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft.
- Published in:
- British Journal of Pharmacology, 2013, v. 170, n. 7, p. 1436, doi. 10.1111/bph.12406
- By:
- Publication type:
- Article